The impact of CD4 +Foxp3 + Treg on immunity to murine cytomegalovirus after bone marrow transplantation depends on the peripheral or thymic source of T cell regeneration

Transplant Immunology

Volumn 24, Issue 1, 2010, Pages 9-16

  Bruinsma, Marieke ^a   Wils, Evert Jan ^a   Löwenberg, Bob ^a   Cornelissen, Jan J ^a   Braakman, Eric ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bone marrow transplantation; LIP; MCMV; Regulatory T cells; Thymopoiesis

Indexed keywords

CD4 ANTIGEN; RAG2 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL EXPANSION; CELL REGENERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEATH; IMMUNOCOMPETENCE; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; REGULATORY T LYMPHOCYTE; SURVIVAL RATE; T CELL DEPLETION; VIRUS IMMUNITY; VIRUS LOAD;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD4; BONE MARROW TRANSPLANTATION; CELL SURVIVAL; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; HERPESVIRIDAE INFECTIONS; LYMPHOPOIESIS; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; REGENERATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; VIRAL LOAD; VIRULENCE;

EID: 78449253235     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2010.08.003     Document Type: Article

References (39)

1. Broers A.E., van der Holt B., Haze S., Braakman E., Gratama J.W., Lowenberg B., et al. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation. Exp Hematol 2005, 33:912-919.
2. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 2006, 354:1813-1826.
3. Ho V.T., Soiffer R.J. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001, 98:3192-3204.
4. Kim D.H., Sohn S.K., Won D.I., Lee N.Y., Suh J.S., Lee K.B. Rapid helper T-cell recovery above 200×10 6/l at 3months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant 2006, 37:1119-1128.
5. Storek J., Gooley T., Witherspoon R.P., Sullivan K.M., Storb R. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol 1997, 54:131-138.
6. Quinnan G.V., Kirmani N., Rook A.H., Manischewitz J.F., Jackson L., Moreschi G., et al. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 1982, 307:7-13.
7. Gratama J.W., van Esser J.W., Lamers C.H., Tournay C., Lowenberg B., Bolhuis R.L., et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001, 98:1358-1364.
8. Gratama J.W., Brooimans R.A., van der Holt B., Sintnicolaas K., van Doornum G., Niesters H.G., et al. Monitoring cytomegalovirus IE-1 and pp 65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations. Cytometry B Clin Cytom 2008, 74:211-220.
9. Meij P., van Esser J.W., Niesters H.G., van Baarle D., Miedema F., Blake N., et al. Impaired recovery of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood 2003, 101:4290-4297.
10. June C.H., Blazar B.R. Clinical application of expanded CD4+25+ cells. Semin Immunol 2006, 18:78-88.
11. Nguyen V.H., Zeiser R., Negrin R.S. Role of naturally arising regulatory T cells in hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006, 12:995-1009.
12. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
13. Cohen J.L., Trenado A., Vasey D., Klatzmann D., Salomon B.L. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 2002, 196:401-406.
14. Hoffmann P., Ermann J., Edinger M., Fathman C.G., Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002, 196:389-399.
15. Taylor P.A., Lees C.J., Blazar B.R. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002, 99:3493-3499.
16. Taylor P.A., Panoskaltsis-Mortari A., Swedin J.M., Lucas P.J., Gress R.E., Levine B.L., et al. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 2004, 104:3804-3812.
17. Thornton A.M., Shevach E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000, 164:183-190.
18. Edinger M., Hoffmann P., Ermann J., Drago K., Fathman C.G., Strober S., et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003, 9:1144-1150.
19. Jones S.C., Murphy G.F., Korngold R. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant 2003, 9:243-256.
20. Trenado A., Charlotte F., Fisson S., Yagello M., Klatzmann D., Salomon B.L., et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 2003, 112:1688-1696.
21. Boeckh M., Leisenring W., Riddell S.R., Bowden R.A., Huang M.L., Myerson D., et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003, 101:407-414.
22. Boeckh M., Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 2009, 113:5711-5719.
23. Wils E.J., Braakman E., Verjans G.M., Rombouts E.J., Broers A.E., Niesters H.G., et al. Flt3 ligand expands lymphoid progenitors prior to recovery of thymopoiesis and accelerates T cell reconstitution after bone marrow transplantation. J Immunol 2007, 178:3551-3557.
24. Reddehase M.J., Simon C.O., Seckert C.K., Lemmermann N., Grzimek N.K. Murine model of cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol 2008, 325:315-331.
25. Broers A.E., Posthumus-van Sluijs S.J., Spits H., van der Holt B., Lowenberg B., Braakman E., et al. Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants. Blood 2003, 102:1534-1540.
26. Broers A.E., Meijerink J.P., van Dongen J.J., Posthumus S.J., Lowenberg B., Braakman E., et al. Quantification of newly developed T cells in mice by real-time quantitative PCR of T-cell receptor rearrangement excision circles. Exp Hematol 2002, 30:745-750.
27. De Wilde V., Benghiat F.S., Novalrivas M., Lebrun J.F., Kubjak C., Oldenhove G., et al. Endotoxin hyperresponsiveness upon CD4+ T cell reconstitution in lymphopenic mice: control by natural regulatory T cells. Eur J Immunol 2008, 38:48-53.
28. Almeida A.R., Legrand N., Papiernik M., Freitas A.A. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 2002, 169:4850-4860.
29. Winstead C.J., Fraser J.M., Khoruts A. Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells. J Immunol 2008, 180:7305-7317.
30. Shen S., Ding Y., Tadokoro C.E., Olivares-Villagomez D., Camps-Ramirez M., Curotto de Lafaille M.A., et al. Control of homeostatic proliferation by regulatory T cells. J Clin Invest 2005, 115:3517-3526.
31. Annacker O., Pimenta-Araujo R., Burlen-Defranoux O., Barbosa T.C., Cumano A., Bandeira A. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 2001, 166:3008-3018.
32. Earle K.E., Tang Q., Zhou X., Liu W., Zhu S., Bonyhadi M.L., et al. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol 2005, 115:3-9.
33. Podlech J., Holtappels R., Wirtz N., Steffens H.P., Reddehase M.J. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. J Gen Virol 1998, 79(Pt 9):2099-2104.
34. Polic B., Hengel H., Krmpotic A., Trgovcich J., Pavic I., Luccaronin P., et al. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 1998, 188:1047-1054.
35. Daniels K.A., Devora G., Lai W.C., O'Donnell C.L., Bennett M., Welsh R.M. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med 2001, 194:29-44.
36. Krmpotic A., Bubic I., Polic B., Lucin P., Jonjic S. Pathogenesis of murine cytomegalovirus infection. Microbes Infect 2003, 5:1263-1277.
37. Klenovsek K., Weisel F., Schneider A., Appelt U., Jonjic S., Messerle M., et al. Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood 2007, 110:3472-3479.
38. Jonjic S., Pavic I., Polic B., Crnkovic I., Lucin P., Koszinowski U.H. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 1994, 179:1713-1717.
39. Nguyen V.H., Shashidhar S., Chang D.S., Ho L., Kambham N., Bachmann M., et al. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood 2008, 111:945-953.